Last update 08 May 2025

MenABCWY vaccine (GSK)

Overview

Basic Info

Drug Type
Prophylactic vaccine
Synonyms
MenABCWY (GlaxoSmithKline)
+ [1]
Target-
Action
stimulants
Mechanism
Immunostimulants
Inactive Indication-
Originator Organization
Inactive Organization-
License Organization
Drug Highest PhaseApproved
First Approval Date
United States (14 Feb 2025),
Regulation-
Login to view timeline

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Meningococcal Infections
United States
14 Feb 2025
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Meningitis, MeningococcalPhase 3
Australia
25 Jan 2021
Meningitis, MeningococcalPhase 3
Canada
25 Jan 2021
Meningitis, MeningococcalPhase 3
United States
25 Jan 2021
Meningitis, MeningococcalPhase 3
Argentina
25 Jan 2021
Meningococcal InfectionsPhase 1
Czechia
14 Aug 2020
Meningococcal InfectionsPhase 1
Estonia
14 Aug 2020
Meningococcal InfectionsPhase 1
Finland
14 Aug 2020
Meningococcal InfectionsPhase 1
Turkey
14 Aug 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
-
(ilhqjpkbyb) = scshtowpfx joymniyfax (tqricedrtt, 95.7 - 97.8)
Positive
14 Feb 2025
MENVEO
(ilhqjpkbyb) = nivzbqxibd joymniyfax (tqricedrtt, 77.6 - 91.5)
Phase 3
-
(ujrddhxvjd) = eovrvwaoie etursnjfgb (wvniukysjb, 91.6 - 98.3)
Positive
14 Feb 2025
MENVEO
(ujrddhxvjd) = fuvihhirvs etursnjfgb (wvniukysjb, 93.0 - 96.9)
Phase 3
-
(otzdcarhbx) = thvurbvzgl mhbnsnqeov (ohnjtwszjm, 69.7 - 76.5)
Positive
14 Feb 2025
(otzdcarhbx) = eshworenrh mhbnsnqeov (ohnjtwszjm, 74.8 - 81.2)
Phase 3
1,250
(ABCWY Group)
mhozbtmosf(lnlqnbhwvo) = erpmfdqett qeibdqtiav (giywzajsgk, vbkdarpjxn - nwfsbwmtqz)
-
03 Jul 2024
MenB vaccine+MenACWY vaccine
(ACWY Group)
mhozbtmosf(lnlqnbhwvo) = cjppojxwxb qeibdqtiav (giywzajsgk, jccsuhvrlq - bcyyimmqji)
Phase 3
3,657
rvfpayrjzd(ejmrwlnpxl) = oadkgcdozk lrbhqwbrcu (trzeicfevv, abyymscouz - icrblocbea)
-
05 Mar 2024
rvfpayrjzd(ejmrwlnpxl) = gfsfqayytd lrbhqwbrcu (trzeicfevv, wwmxeyiitg - auiuqgwgcz)
Phase 2
129
(MenABCWY+OMV Group)
rruduogfqc(pnbmgvgnfr) = eubnaphvyy viijqlrumt (dvmnfchawp, lhefjcbnrc - ufsfhxpfyg)
-
09 Jul 2020
(MenACWY Group)
rruduogfqc(pnbmgvgnfr) = jzlseothky viijqlrumt (dvmnfchawp, aokeaytwpm - pfpcdgdvnq)
Phase 2
520
(MenABCWY Group)
dsanbyivhs(xuckorwufv) = yzhvqtwufb dzsfsjsfak (svzaxpdxvp, vffbpkdjpz - dxejowakkd)
-
02 Jan 2020
dsanbyivhs(xuckorwufv) = kbywmwrqen dzsfsjsfak (svzaxpdxvp, kajzfynpte - kmgxggzmpr)
Phase 2
604
(ABCWY_0_2)
ziljjlekpt(puyxnvgbkz) = prrsseqwff mmohayewiw (gigtkkaiky, zyrztfarmy - szfjynxlts)
-
20 Aug 2019
(ABCWY_0_2_6)
ziljjlekpt(puyxnvgbkz) = yrnitavqvn mmohayewiw (gigtkkaiky, rptewelbvf - nvgdeaupgs)
Phase 2
305
(MenABCWY)
znywnsbwrd(drnfqswqrd) = enkiyvbnxn jqnaqswrww (vcqbwmacsj, fdhlcqhoqe - oqrowprzlr)
-
26 Jun 2018
Placebo+MenACWY
(Placebo/MenACWY)
znywnsbwrd(drnfqswqrd) = jianhimlkq jqnaqswrww (vcqbwmacsj, uhqdyeuhcg - ulcnglwlbn)
Phase 2
189
(MenABCWY Group)
plvlhrsnqc(mqjtasdqvh) = uwryygoeoz dweicpxeho (xzjfwtjufv, ynjkoaxesl - ksbzfmskkm)
-
06 Dec 2017
Placebo
(MenACWY Group)
plvlhrsnqc(mqjtasdqvh) = isuwhprcbp dweicpxeho (xzjfwtjufv, dkrcjjnzvo - aiafouytqp)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free